Hoa Lac Stem Cell JSC (HSC) is a pioneer in researching, developing, manufacturing, and distributing stem cells in Vietnam. We advocate the research and transfer of advanced stem cell technology into Vietnam on the basis of joint research, and investment between HSC and local and foreign partners who share the same goal of contributing to the development of stem cell technology in Vietnam.
Our mission
HSC is committed to the research, development and transfer of advanced stem-cell technology for sustainable development and improvement of public health.
Our vision
To become a leading supplier of stem cells and stem-cell technology in Vietnam and South East Asia.
HSC Stem Cell Technology Platform (HOSTEP) project is the first Stem Cell Technology Platform in Vietnam that provides cGMP-compliant stem cell products.
Foreword
Hoalac Stem Cell (HSC) stands as a pioneer in the application of advanced biomedical technologies dedicated to community healthcare and treatment. We are strategically focused on the research, development, and technology transfer of cutting-edge solutions from prestigious domestic and international partners. By leading the way in cell and gene therapies, HSC is committed to advancing the landscape of innovative biomedical applications in Vietnam.
Driven by a team of distinguished experts and a state-of-the-art system of cell and tissue banks, our facilities are rigorously invested to meet global benchmarks, including AABB, GMP, cGMP, ISO, ISCT, and FACT. HSC is dedicated to partnering with medical and aesthetic institutions to deliver healthcare and beauty solutions that are proactive, safe, effective, and evidence-based.
In parallel with enhancing the capabilities of our professional team, HSC regularly updates and invests in modern equipment systems that meet the stringent requirements of the biomedical field, ensuring transparent and international-standard service quality.
Our mission is to accompany our customers, partners, and the community on the journey to enhance quality of life, contributing to the development of a modern, humane, and sustainable healthcare system, while opening new hopes for access to advanced biomedical solutions for complex diseases
Chairman of the Board
PhD. Doctor. Bach Huy Anh.